YOU OR YOUR CHILD MAY BE ELIGIBLE FOR ONE OF THE SCENIC CLINICAL TRIALS IF
Diagnosed with XLRP and have RPGR gene mutation (confirmed by genetic testing)
Visual Acuity is between 20/32 and 20/200
Between 8 and 50 years of age
SCENIC CLINICAL TRIAL PARTICIPATION
Clinical research studies help scientists and doctors explore whether a medical therapy is safe and effective in humans. The data gathered from clinical research helps the development of medical therapies, which may improve how patients receive medical care and the way they are treated for their conditions.
There is no guarantee that this investigational gene therapy will improve you or your child’s XLRP symptoms, but what researchers learn may lead to better medications and treatments for patients with XLRP in the future.
By continuing to access this website you are giving us consent to collect cookies.